Page 452 - Handbook of Biomechatronics
P. 452

446                                                    Graham Brooker


          maximum. The slow secretion is generated by new insulin secretory gran-
          ules and is proportional to the glucose concentration.

                                    SR tðÞ ¼ mF tðÞ                     (8)
          where SR is the secretion rate and F is the ready realizable insulin
          described by

                                _
                                FtðÞ ¼  mF tðÞ + YG, tÞ
                                                ð
          with initial conditions F(0) ¼ F 0 , where F 0 is the amount of insulin released
          immediately after the glucose stimulus. Y(G,t) is the provision of new insulin
          that depends on the glucose level
                                      1
                            _
                                                   ð
                                          ð
                             ð
                           YG, tÞ ¼   ½  YG, tÞ YG, ∞ފ
                                      T
          where Y(0) ¼ 0 and

                                     0           if GtðÞ < h
                         YG, ∞Þ ¼
                          ð
                                      ½
                                     β GtðÞ hŠ   if GtðÞ   h
          These rather complex subsystem models can be integrated into a complete
          model of the glucose-insulin control system as shown in Fig. 25.
             For conventional physical systems, equations can be developed from first
          principles to accurately describe their behavior, whereas maximal models of
          physiological processes rely on the interpretation of measurements. Those
          issues notwithstanding, complex models provide answers to “what if” ques-
          tions in a teaching environment and more importantly to assess control algo-
          rithms and different insulin diffusion techniques. This method is sufficiently
          advanced that the FDA has accepted in silico trials using maximal models as a
          substitute to preclinical animal studies (Cobelli et al., 2009).


          5.2 Closed-Loop Control
          Control schemes can be open or closed loop, both of which aim to keep
          blood glucose within a desired range by compensating for disturbances using
          insulin. Typically, open-loop methods do not use real-time data to make
          their decisions whereas the closed-loop system exploits real-time measure-
          ments correlated with the control variable to react to disturbances.
             A completely open-loop system would rely on fixed basal insulin admin-
          istration throughout the day with additional boluses at meal times, based on
          patient characteristics without glucose measurements. Such a control system
   447   448   449   450   451   452   453   454   455   456   457